Publications

2014

Lucas JT, Kuremsky JG, Soike M, Hinson W, Kearns WT, Blackstock AW, Urbanic JJ. Comparison of Accelerated Hypofractionation and Stereotactic Body Radiotherapy for Stage 1 & Node Negative Stage 2 Non-Small Cell Lung Cancer (NSCLC). Lung Cancer. 2014 Jul;85(1):59-65. PMID: 24813936

Kilburn, Jeremy M.; Lester, Scott C.; Lucas, John T. Jr; Soike, Michael H.; Blackstock, A. William; Kearns, William T.; Hinson, William H.; Miller, Antonius A.; Petty, William J.; Munley, Michael T.; Urbanic, James J. Management of Mediastinal Relapse after Treatment with Stereotactic Body Radiotherapy or Accelerated Hypofractionated Radiotherapy for Stage I/II Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(4):572-576, April 2014. PMID 24736084.

Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD. A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol. 2014 Feb 20. [Epub ahead of print] PMID: 24558022

Kilburn JM, Ellis TL, Lovato JF, Urbanic JJ, Daniel Bourland J, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity? J Neurooncol. 2014 Feb 7. [Epub ahead of print] PMID: 24504497

Kilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, Lovato JF, Miller AA, Petty WJ, Urbanic JJ. Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol. 2014 Mar;110(3):505-10. PMID: 24444530

2013

Salama JK, Pang H, Bogart JA, Blackstock AW, Urbanic JJ, Hodgson L, Crawford J, Vokes EE Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. Lung Cancer. 2013 Dec;82(3):436-40. PMID: 24396884

Kuremsky J, Urbanic JJ, Jeff Petty W, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MD. Tumor Histology Predicts Patterns of Failure and Survival in Patients with Brain Metastases from Lung Cancer Treated with Gamma Knife Radiosurgery. Neurosurgery. 2013 Oct; 73(4):641-7. PMID: 23842552. PMCID – in process.

Salama JK, Hodgson L, Pang H, Urbanic JJ, Blackstock AW, Schild SE, Crawford J, Bogart JA, Vokes EE; for the Cancer and Leukemia Group B. A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemotherapy Followed by Concurrent Platinum-Based Chemotherapy and 70 Gy Daily Radiotherapy: CALGB 30904. J Thorac Oncol. 2013 Aug;8(8):1043-1049. PMID: 23715301. PMCID: PMC3822578

2012

Patel PR, Yoo DS, Niibe Y, Urbanic JJ, Salama JK. A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. Pulm Med. 2012;2012:480961. doi: 10.1155/2012/480961. Epub 2012 Oct 17. PMCID: PMC3483729

Loganathan AG, Chan MD, Alphonse N, Peiffer AM, Johnson AJ, McMullen KP, Urbanic JJ, Saconn PA, Bourland JD, Munley MT, Shaw EG, Tatter SB, Ellis TL. Clinical outcomes of brain metastases treated with Gamma Knife radiosurgery with 3.0 T versus 1.5 T MRIbased treatment planning: have we finally optimized detection of occult brain metastases? J Med Imaging Radiat Oncol. 2012 Oct;56(5):554-60. doi: 10.1111/j.1754-9485.2012.02429.x. Epub 2012 Jul 30. PMID: 23043576

Vern-Gross TZ, Lawrence JA, Case LD, McMullen KP, Bourland JD, Metheny-Barlow LJ, Ellis TL, Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol. 2012 Dec;110(3):381-8. doi: 10.1007/s11060-012-0976-3. Epub 2012 Sep 24. PMID: 23001361 James John Urbanic, MD Page 10 of 17 30 September 2015

Cochran DC, Chan MD, Aklilu M, Lovato JF, Alphonse NK, Bourland JD, Urbanic JJ, McMullen KP, Shaw EG, Tatter SB, Ellis TL. The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. J Neurosurg. 2012 May;116(5):978-83. Epub 2012 Mar 2. PMID: 22385005. PMCID: PMC3791504

Harris S, Chan MD, Lovato JF, Ellis TL, Tatter SB, Bourland JD, Munley MT, deGuzman AF, Shaw EG, Urbanic JJ, McMullen KP. Gamma Knife stereotactic radiosurgery as salvage therapy after failure of whole brain radiotherapy with small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e53-9. Epub 2012 Feb 17. PMID: 22342297. PMCID: PMC3791505

2011

Petty WJ, Voelzke WR, Urbanic JJ, Varela VA, Waller LL, Swift CB, Graham RM, Memoli VA, Dragnev KH. High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer. Lung Cancer. 2011 Dec; 74(3): 384-91. PMID: 21555162

Lowell D, Tatter SB, Bourland JD, Deguzman AF, Ekstrand KE, Ellis TL, Lovato JF, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Chan MD. Toxicity of gamma knife radiosurgery in the treatment of intracranial tumors in patients with collagen vascular disease or multiple sclerosis. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4): e519-24. PMID: 21601376

Jensen CA, Chan MD, McCoy TP, Bourland JD, Deguzman AF, Ellis TL, Ekstrand KE, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Tatter SB. Cavity-directed radiosurgery as adjuvant resection of a brain metastasis. J Neurosurg 2011 June; 114(6): 1585-91. PMID 21166567. PMCID: PMC3789371

2010 and Earlier

Urbanic JJ, Lally B, Blackstock AW. The best laid plans often go …. Awry. J Thoracic Oncology 2009 4(7): 783-4. PMID 19550240

Lally BE, Urbanic JJ, Blackstock AW. Could it be that less is more? Lancet Oncology 2009; 10(5): 435-7. PMID 19410187

Lally BE, Geiger AM, Urbanic JJ, Butler JM, Wentworth S, Perry MC, Wilson LD, Horton JK, Detterbeck FC, Miller AA, Thomas CR, Blackstock AW. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer 2009; 64(2); 226-31. PMID 18835059

Rossi PJ, Urbanic J, Clark PE, McCullough DL, Lee WR. Pretreatment PSAV is associated with freedom from biochemical recurrence of prostate cancer after low dose rate prostate brachytherapy alone. Brachytherapy 2008; Oct-Dec: 7(4): 286-289. PMID 18928924

Urbanic JJ, Lally BE, Blackstock AW. Preoperative Chemoradiotherapy for Superior Sulcus Tumors: JCOG 9806 Validation of an Induction Therapy Approach. Amer J Hem Oncol (Review) 2008.

Kearns WT, Urbanic JJ, Hampton CJ, McMullen KP, Blackstock AW, Stieber VW., Hinson WH. Radiation safety issues with PET/CT simulation for Stereotactic Body Radiation James John Urbanic, MD Page 11 of 17 30 September 2015 Therapy. Journal of Applied Clinical and Medical Physics 2008; 9(3): 141-146. PMID 18716587

Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC. Small cell lung cancer: Have we made any progress over the last 25 years? Oncologist 2007 Sept; 12(9):1096-104. PMID 17914079

Papagikos MA, Rossi PJ, Urbanic JJ, deGuzman AF, McCullough DL, Clark PE, Lee WR. A simple model predicts freedom from biochemical recurrence following low-dose-rate prostate brachytherapy alone. Am J Clin Oncol 2007 April; 30: 199-204. PMID 17414471

Urbanic JJ, Lee WR. Confidence Intervals and Survival Estimates: A systematic review of three oncology journals. Am J Clin Oncol 2006 Aug; 29: 405-407. PMID 16891871

Urbanic JJ, Blackstock AW. Radiotherapy for Small Cell Lung Cancer. American Society of Clinical Oncology Annual Meeting Educational Book 2006; 442-444.

Urbanic JJ, Lee WR. Update on brachytherapy in prostate cancer: The importance of dosimetry. Curr Opin Urol 2006 May; 16: 157-161. PMID 16679852

Urbanic JJ, Turrisi AT, Sharma AK, Silvestri GA, Williams TE, Vanek KN, Sherman CA. Conformal high-dose external radiation therapy (CHERT), 80.5 Gy, alone for medically inoperable non-small cell lung cancer (MILC) - a retrospective analysis. J Thoracic Oncol 2006 Feb; 1: 112-119. PMID 17409839

Rocha Lima CM, Urbanic JJ, Lal A, Kneuper-Hall R, Brunson CY, Green MR. Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies. Semin Oncol 2001 Jun; 28(3 Suppl 10): 34-43. PMID 11510032

Rocha Lima CM, Urbanic JJ, Sherman CA, Brescia FJ, Green MR. Docetaxel followed by gemcitabine and irinotecan in solid tumors. Oncology(Huntingt). 2001 Jan; 15(1 Suppl 1):37- 45. PMID 11221020